Panacea Index Logo

Command Palette

Search for a command to run...

Antihyperlipidemic activity of adenosine triphosphate in rabbits fed a high-fat diet and hyperlipidemic patients.

Pharmaceutical biology
October 1, 2016
Lianshan Zhang et al. (6 authors)
Controlled Clinical TrialJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the anti-hyperlipidemic effects of ATP in a high-fat diet rabbit model and hyperlipidemic patients.

Results Summary

ATP significantly decreased serum triglyceride (TG) levels in both high-fat diet rabbits and hyperlipidemic patients, while other lipid parameters remained unchanged. It also reduced fat layer thickness in cardiac epicardium and pathological gradation of ballooning degeneration in hepatocytes.

Population

High-fat diet-fed rabbits and hyperlipidemic outpatients.

Effective Dosage

40 mg/day for rabbits, 60 mg twice a day for patients.

Duration

10 days for rabbits, 1 week for patients.

Interactions

None mentioned

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
high-fat diet
increase
lipid parameters including TC, TG, LDL-C, VLDL-C
rabbits
-
resulted in a significant elevation
#1
ATP treatment
decrease
serum TG level
high-fat fed rabbits
-
significantly decreased
#2
ATP treatment
no change
other parameters
high-fat fed rabbits
-
remained statistically unaltered
#3
ATP
decrease
thickness of fat layer in cardiac epicardium
high-fat fed rabbits
-
significantly reduced
#4
ATP
decrease
pathological gradation of ballooning degeneration in hepatocytes
high-fat fed rabbits
-
significantly reduced
#5
ATP
decrease
TG
hyperlipidemia patients
-
exhibited a significant decrease
#6
ATP
no change
other lipid parameters
hyperlipidemia patients
-
had no significant change
#7
ATP supplementation
decrease
serum TG levels
high-fat diet rabbits and hyperlipidemic patients
-
selectively decreases
#8
Abstract

Context Recently, adenosine triphosphate (ATP) was occasionally found to decrease the triglyceride (TG) levels in several hyperlipidemic patients in our clinical practice. Objective The study investigates the anti-hyperlipidemic effects of ATP in a high-fat fed rabbit model and hyperlipidemic patients. Materials and methods Twenty-four rabbits were randomly divided into three groups of eight animals each as follows: normal diet, high-fat diet and high-fat diet + ATP group. ATP supplementation (40 mg/day) was started at the 20th day and lasted for 10 days. Serum concentrations of total cholesterol (TC), TG, LDL-C, HDL-C were measured on the 20th day and 30th day. Heart, liver and aorta were subjected histopathological examination. Twenty outpatients diagnosed primary hyperlipidemia took ATP at a dose of 60 mg twice a day for 1 week. Results Feeding rabbits with a high-fat diet resulted in a significant elevation of lipid parameters including TC, TG, LDL-C, VLDL-C compared to the normal diet group (p < 0.01). ATP treatment significantly decreased serum TG level (p < 0.01), whilst other parameters remained statistically unaltered. Meanwhile, ATP significantly reduced the thickness of fat layer in cardiac epicardium (p < 0.05) and pathological gradation of ballooning degeneration in hepatocytes (p < 0.05). After taking ATP for 1 week, hyperlipidemia patients exhibited a significant decrease of TG (p < 0.01), but other lipid parameters had no significant change. Discussion and conclusion The study indicates that ATP selectively decreases serum TG levels in high-fat diet rabbits and hyperlipidemic patients. Therefore, ATP supplementation may provide an effective approach to control TG level.

Medical Subject Headings (MeSH)
Adenosine TriphosphateAdultAgedAnimalsBiomarkersDiet, High-FatDisease Models, AnimalDown-RegulationFemaleHepatocytesHumansHypercholesterolemiaHypertriglyceridemiaHypolipidemic AgentsMaleMiddle AgedMyocardiumRabbitsTime FactorsTreatment OutcomeTriglycerides
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality70/10
Citation Metrics
Total Citations3
Citations/Year0.3
Relative Citation Ratio0.13
NIH Percentile6.5%
Research Impact Scores
APT Score0.05
Weight Score1.50
Normalized Score0.64
Related Supplements